The latest immunotherapy news and developments
Multiple myeloma is a type of blood cancer that appears mainly after the age of…
University of Houston (USA) researchers and their students are developing a new software technology, based…
In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen…
Ourrent methods for activating T cells don’t resemble closely enough the natural environment in which…
Tumour cachexia is a serious syndrome affecting many cancer patients, who not only lose significant…
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but…
The most comprehensive overview to date of how the immune system reshapes tumour architecture in…
In the largest prospective study to date examining the use of chimaeric antigen receptor (CAR)-T…
Stimulating a key metabolic pathway in T cells can make them work more effectively against…
Results from a preclinical study in mice, and a collaborative clinical study in patients show…